Monopoly Rights for High-Volume Gasotyle Plus

Dominate the Bloating & Digestive Discomfort Market

Gasotyle Plus Edge: Dual-Action Enzyme & Anti-Foaming Relief

Secure Your Competition-Free Gastro Territory Today

Minimal Investment, Maximum Marketing Support & Stock Availability
Launch Your High-Demand Digestive Enzyme Business Now!

Home/Products /alpha-galactosidase-150-mg-simethicone-25-mg-tablet

About the Product

Description


Gasotyle Plus Tablet is a high-volume, general-use product that promises guaranteed prescription flow and impressive returns in the Gastrology segment.

This tablet offers a powerful dual-action formula:

  • Alpha Galactosidase: This enzyme breaks down complex indigestible carbohydrates (oligosaccharides) in the small intestine, preventing fermentation and reducing gas formation at the source.

  • Simethicone: This antifoaming agent works locally to break down existing gas bubbles, aiding in their rapid and comfortable expulsion (burping/flatus).

Why Gasotyle Plus is Your Fastest-Moving Franchise Product:

  • Mass Market Appeal: Directly addresses the most common gastro complaints (bloating, gas) related to modern diet and lifestyle, ensuring universal and consistent prescription demand.

  • Unique Combination Advantage: The dual mechanism offers more comprehensive relief than single-molecule products, driving higher prescription preference from GPs and Specialists.

  • High Inventory Turnover: As a common digestive aid, it boasts one of the fastest sales cycles in the pharma market, guaranteeing quick capital rotation and superior profit realization.

Secure your exclusive Gasotyle Plus territory now! 

This combination is generally well tolerated. Rarely, mild side effects such as nausea, mild diarrhea, or stomach upset may occur. If persistent discomfort or allergic reactions develop, discontinue use and consult a healthcare professional.

Gasotyle Plus Tablet is indicated for the relief of flatulence, bloating, and discomfort due to indigestion or excessive gas. It is especially useful for individuals experiencing digestive issues after consuming gas-producing foods, helping restore comfort and ease.

Take Gasotyle Plus Tablet as directed, usually with meals or immediately after eating gas-producing foods. Do not exceed the recommended dose. Individuals with known allergies to any component should avoid this medication.

Store Gasotyle Plus Tablet in a cool, dry place below 25°C, protected from moisture and sunlight. Keep out of reach of children and do not use after the expiry date.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Alpha Galactosidase 150mg + Simethicone 25mg Tablet in the PCD pharma franchise market?

This combination tablet has strong demand in the gastroenterology and digestive health segment, making it a useful product for medical distributors, wholesalers, and pharma franchise partners focusing on gas, bloating, and indigestion relief portfolios.

Why should medical distributors include this combination tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for digestive enzyme and antiflatulent therapy used in gas formation, abdominal bloating, indigestion, and dietary intolerance-related discomfort. Alpha Galactosidase helps break down complex carbohydrates, while Simethicone reduces gas bubbles, strengthening a digestive care product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this combination tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong gastro OTC and prescription demand, high seasonal usage, daily outpatient prescriptions, reliable supply chain support, and good margins when partnering for this digestive health product.

How can I become a distributor or franchise partner for this tablet?

Medical distributors, stockists, and wholesalers interested in this combination tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.